Medical News

Alarming AMR Rates, a Reason for the Pandemic to Spread?

There are a lot of things that are rising a huge concern among the medical and health community and probably one of the most recent updates would be concerning the disturbing yet alarming numbers when it comes to Antimicrobial resistance.

The Anti-Microbial resistance is a phenomenon that is used to measure the effectiveness of Anti-Microbial treatments on certain diseases. Many countries that are associated with the World Health Organization (WHO) like Geneva conducted research and surveys only to find out that the rates at which Anti-Microbial resistance is increasing by the day and that too at alarming rates.  This is a very strong indication that the anti-microbial treatment that is being prevalently used against in the Coronavirus pandemic are not effective as they are supposed to be.

WHO has raised concerns to the countries to bring in more innovation and stringent methods to make sure that the numbers are kept in a controlled limit. WHO also feels that the way of exposing Anti-Microbial treatments needs to improve on a major scale to help the countries battle more effectively against the pandemic. The organization also says that this will not only help them to treat the people affected by the Pandemic but will also help in keeping the pandemic under control.

WHO initiated GLASS (Global Antimicrobial Resistance and Use Surveillance System) to make sure that they can get data from around the world about AMR (Antimicrobial resistance). The participation of the countries gradually developed and reached an exponential number in just three years and within no time GLASS now has around 64,000 surveillance sites from 66 countries in just three years. WHO is very much concerned that the numbers from these surveillance sites might be the reason why there is still an imbalance in the control of the pandemic in many parts of the world.

The major reason that is being taken into account is the decline of funds from the partners and the private sectors and also the lack of innovation that is happening concerning the treatments. WHO is planning to make sure that they implement effective strategies to keep the AMR rate low.

Owen Easter

Owen Easter is a senior journalist at CapitalBay.News. He has worked as a freelance writer for multiple online science magazines. He updates his readers on the latest medical news, drug updates around the world.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button